These observations point towards a critical involvement of micro-environmental factors such as hypoxia or nutrient-deprivation in steering cell fate after FOXO3-activation and questions FOXO3 as a “typical tumor suppressor protein” in NB therapy. This evidence concerns the gene FOXO3 and neuroblastoma.